Ionis Pharmaceuticals (IONS) director receives 5,220 shares from RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IONIS PHARMACEUTICALS director Spencer R. Berthelsen reported vesting of 5,220 Restricted Stock Units on July 15, 2026, converting into the same number of common shares at no cost. After this conversion, he directly holds 161,233 common shares and 2,301 RSUs. An additional 70 common shares are held indirectly by his daughter, for which he disclaims beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
5,220 shares exercised/converted
Mixed
3 txns
Insider
BERTHELSEN SPENCER R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 5,220 | $0.00 | -- |
| Exercise | Common Stock | 5,220 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 2,301 shares (Direct);
Common Stock — 161,233 shares (Direct);
Common Stock — 70 shares (Indirect, by Daughter)
Footnotes (1)
- Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
Key Figures
Common shares received from RSU vesting: 5,220 shares
Direct common shares after transaction: 161,233 shares
RSUs converted: 5,220 units
+2 more
5 metrics
Common shares received from RSU vesting
5,220 shares
RSUs vested and converted into common stock on July 15, 2026
Direct common shares after transaction
161,233 shares
Total Ionis common stock held directly by Berthelsen after July 15, 2026
RSUs converted
5,220 units
Restricted Stock Units exercised/converted into common stock at $0.0000
RSUs remaining
2,301 units
Restricted Stock Units held directly after the July 15, 2026 conversion
Indirect shares held by daughter
70 shares
Common stock held indirectly, with beneficial ownership disclaimed by Berthelsen
Key Terms
Restricted Stock Unit, beneficial ownership, Section 16, contingent right
4 terms
Restricted Stock Unit financial
"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
beneficial ownership financial
"The reporting person disclaims beneficial ownership of all securities held by his daughter"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
contingent right financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider equity change did Ionis Pharmaceuticals (IONS) disclose for Spencer R. Berthelsen?
Ionis disclosed that director Spencer R. Berthelsen had 5,220 Restricted Stock Units vest and convert into common stock at no cost. Following this, he directly holds 161,233 common shares and retains 2,301 RSUs as of July 15, 2026.
What happened to Spencer R. Berthelsen’s Restricted Stock Units in the Ionis (IONS) filing?
On July 15, 2026, 5,220 Restricted Stock Units vested and were converted into the same number of Ionis common shares at a $0.00 exercise price. After this conversion, Berthelsen still holds 2,301 RSUs subject to the plan’s vesting and delivery terms.
What are the key vesting terms for Ionis (IONS) Restricted Stock Units reported by Spencer R. Berthelsen?
The RSUs vest 100% on the first anniversary of grant or the next annual stockholders’ meeting, whichever is earlier. They are delivered to the reporting person on the July 15 following vesting and may be settled in Ionis common stock or cash, at the company’s discretion.